Clinical Trial Update: NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

An update on NB1011 for metastatic or recurrent colorectal cancer in Phase 1/Phase 2, sponsored by NewBiotics, with the current status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• NB1011

Snippet

Sponsor: NewBiotics | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: UNKNOWN